Celligenics
Biotechnology Research
Chromos, Sg
8 employees
- Employees
- 8
Celligenics Overview
- Headquarters
- Chromos, Sg
- Phone Number
- Available in AeroLeads
- Website
- celligenics.com
- Industry
- Biotechnology Research
- Employees
- 8
- Founded
- 2016
- Funding
- 4.2M
- Company Email
- Available in AeroLeads
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
Keywords
About Celligenics
Celligenics is a biotechnology company specialised in the development of future-relevant solutions through stem cell technology in a new era of regenerative medicine. Celligenics aims to be a global leader in the innovative isolation and application of human stem cells and its derivatives, and to empower humanity with unprecedented regenerative healthcare solutions that will enhance the quality of human life. Celligenics possesses strong credentials in the dual-facet of enterprise development and scientific research. The collective team has core expertise in enterprise strategy, investment finance, research & development, as well as experience in the field of working with molecular and cell biology.
Celligenics Contact Details
- People in AeroLeads
- 3
Celligenics Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| Winston Lumenta | Head of Corporate & Business |
View
|
|
| Kurt Wee | Chief Executive Officer at Celligenics | Singapore |
View
|
| Koh Choon Hui | Chairmen Otsaw Digital Pte Ltd |
View
|
Employees by Management Level
Executive
1 profile
VP / Head
1 profile
Individual contributor
1 profile
Compare Similar Companies to Celligenics
Amgen
Biotechnology Research
A*STAR - Agency for Science, Technology and Research
Research Services
IPI Singapore
Business Consulting And Services
Amplify Health
Technology, Information And Internet
National Research Foundation Singapore
Government Administration
Hummingbird Bioscience
Biotechnology Research
Hilleman Laboratories
Research Services
Transwap
Financial Services
Austrianova
Biotechnology Research
Albatroz Therapeutics
Biotechnology